Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 7, 2018
[ Thu, Jun 07th 2018
] - WOPRAI
[ Thu, Jun 07th 2018
] - WOPRAI
[ Thu, Jun 07th 2018
] - WOPRAI
[ Thu, Jun 07th 2018
] - WOPRAI
Wed, June 6, 2018
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
[ Wed, Jun 06th 2018
] - WOPRAI
Tue, June 5, 2018
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
[ Tue, Jun 05th 2018
] - WOPRAI
David Novak Maintained (ZYME) at Buy with Increased Target to $27 on, Jun 5th, 2018
David Novak of Raymond James, Maintained "Zymeworks Inc." (ZYME) at Buy with Increased Target from $22 to $27 on, Jun 5th, 2018.
David has made no other calls on ZYME in the last 4 months.
There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Upgraded from Sell to Hold on, Friday, May 11th, 2018
This is the rating of the analyst that currently disagrees with David
- Jim Birchenough of "Wells Fargo" Maintained at Buy with Increased Target to $37 on, Monday, June 4th, 2018
